Gather Info to Support Safe DOAC Use in Special Populations
November 2026
Using direct oral anticoagulants (DOACs) isn't always simple in special populations...such as patients with kidney or liver disease, etc.
DOACs include apixaban, dabigatran, edoxaban, and rivaroxaban.
These anticoagulants help thin the blood if patients develop serious clots...or if they’re at high clotting risk due to knee or hip surgery, heart rhythm problems, etc.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote